Skip to main content
. 2003 Sep-Dec;9(9-12):209–219.

Figure 3.

Figure 3

Predicted promiscuity of peptides for binding with high affinity to different HLA-DR molecules at 3% threshold (▪); frequency of peptides binding to 9 different HLA-DR molecules (□); frequency of responders to peptides tested in proliferation assay with PBMC of 19 treated and healed nonanergic PCM patients (▧).